Dr Rob Riley is a highly experienced and seasoned Biopharmaceutical leader and proven drug hunter with over 30 years’ experience in Biopharmaceutical Research & Development across many major therapeutic areas. A pharmacologist by training with a keen eye for compound properties and quality, he oversaw the delivery of many meaningful medicines, including Kengreal and Brilinta, while in pharma (Fisons, Astra, Astrazeneca; ~25 years) as Head of DMPK and Chemistry. Recently he served as Head of Worldwide DMPK at Evotec and Executive VP at Cyprotex.